![J.P. Steve Hsu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 335 720 $ am 31.07.2026
J.P.
Steve Hsu is the founder of Genovior Biotech Corp., founded in 2015, serving as Chairman & Chief Executive Officer since 2015.
Former job includes Chief Executive Officer at Polaris Group from 2023 to 2025.
Education includes a doctorate from the Massachusetts Institute of Technology.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
POLARIS GROUP 0,11 % | 23.03.2025 | 1.000.000 ( 0,11 % ) | 335 720 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
Genovior Biotech Corp.
 Genovior Biotech Corp. BiotechnologyHealth Technology Operates as contract development and manufacturing organization | Vorstandsvorsitzender | 01.01.2015 |
| Unternehmen | Position | Ende |
|---|---|---|
| POLARIS GROUP | Vorstandsvorsitzender | 24.12.2025 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 3 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Polaris Group
 Polaris Group BiotechnologyHealth Technology Engages in research and development of protein drugs to treat cancer and other debilitating diseases in humans | Health Technology |
Genovior Biotech Corp.
Genovior Biotech Corp. BiotechnologyHealth Technology Operates as contract development and manufacturing organization | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
